Grigoriy A. Yanus
Saint Petersburg, SPE 194100, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectives.
Journal: Exploration of targeted anti-tumor therapy
Published: March 19, 2025
Diversity of the Circulating Tumor Markers: Perspectives of a Multimodal Liquid Biopsy.
Journal: Biochemistry. Biokhimiia
Published: December 08, 2024
The Spectrum of Disease-Associated Alleles in Countries with a Predominantly Slavic Population.
Journal: International journal of molecular sciences
Published: July 18, 2024
Founder vs. non-founder BRCA1/2 pathogenic alleles: the analysis of Belarusian breast and ovarian cancer patients and review of other studies on ethnically homogenous populations.
Journal: Familial cancer
Published: April 20, 2022
Changes in the concentration of EGFR-mutated plasma DNA in the first hours of targeted therapy allow the prediction of tumor response in patients with EGFR-driven lung cancer.
Journal: International journal of clinical oncology
Published: September 06, 2021
Identification of recurrent pathogenic alleles using exome sequencing data: Proof-of-concept study of Russian subjects.
Journal: European journal of medical genetics
Published: June 08, 2021
Tumor irradiation may facilitate the detection of tumor-specific mutations in plasma.
Journal: World journal of clinical oncology
Published: April 28, 2021
Content of circulating tumor DNA depends on the tumor type and the dynamics of tumor size, but is not influenced significantly by physical exercise, time of the day or recent meal.
Journal: Cancer genetics
Published: December 30, 2020
Revisiting multiple erroneous genetic testing results and clinical misinterpretations in a patient with Li-Fraumeni syndrome: lessons for translational medicine.
Journal: Hereditary cancer in clinical practice
Published: June 24, 2020
Efficacy of immune checkpoint blockade in MUTYH-associated hereditary colorectal cancer.
Journal: Investigational new drugs
Published: June 26, 2019
Last Updated: 09/26/2026